ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
3.920
-0.060 (-1.51%)
Nov 20, 2026, 4:00 PM EST - Market closed
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $48.83 million as of November 20, 2026. It is the 29,651st most valuable company in the world and the 4,514th biggest in the United States. Its market cap has decreased by 40.43% in one year.
Market Cap
48.83M
Enterprise Value
-76.46M
1-Year Change
-40.43%
Global Rank
Country Rank
#4,514 United States
Category
ChartMarket Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $183.04M to $48.83M, a decrease of -73.32%. That is a compound annual growth rate of -63.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 44.50M | -42.33% |
| Dec 31, 2025 | 77.15M | -57.85% |
| Jul 28, 2025 | 183.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Milestone Pharmaceuticals | 52.29M |
| Aldeyra Therapeutics | 50.70M |
| Clene | 50.69M |
| Acrivon Therapeutics | 49.28M |
| Heron Therapeutics | 48.04M |
| Conexeu Sciences | 47.79M |
| Oncolytics Biotech | 47.66M |
| Verrica Pharmaceuticals | 47.07M |